Patent · US Active

Compounds and methods for kinase modulation, and indications therefor

US10426760B2 · kind B2 · utility

5Cited by
132References
52Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2018
Grant dateOct 1, 2019
Priority date
Expiry dateAug 22, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.